Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.70 |
| ▸ | NAAA | Q02083 | 1/20 | 0.66 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | FAAH | O00519 | 3/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.54 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.53 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.51 |
| ▸ | RRM1 | P23921 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17817620 | 0.98 | CASP2 (0.74) | CASP2NAAASLC6A5HPGDFAAH | |
| SCHEMBL27836368 | 0.98 | CASP2 (0.74) | CASP2NAAASLC6A5HPGDFAAH | |
| SCHEMBL28688783 | 0.98 | CASP2 (0.74) | CASP2NAAASLC6A5HPGDFAAH | |
| SCHEMBL11739321 | 0.98 | CASP2 (0.74) | CASP2NAAASLC6A5HPGDFAAH | |
| SCHEMBL13019125 | 0.98 | CASP2 (0.74) | CASP2NAAASLC6A5HPGDFAAH | |
| SCHEMBL24412649 | 0.98 | CASP2 (0.74) | CASP2NAAASLC6A5HPGDFAAH | |
| Hydrochloric Acid SCHEMBL20542987 | 0.96 | CASP2 (0.71) | CASP2NAAASLC6A5HPGDFAAH | |
| Hydrochloric Acid SCHEMBL23000981 | 0.96 | CASP2 (0.71) | CASP2NAAASLC6A5HPGDFAAH | |
| SCHEMBL3550215 | 0.94 | CASP2 (0.61) | CASP2NAAASLC6A5HPGDFAAH | |
| SCHEMBL22522082 | 0.92 | SLC6A5 (0.64) | CASP2NAAASLC6A5HPGDFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3233209-B1 | COSMETIC METHOD FOR CONTROLLING ODORS | OREAL (FR) | 2019-03-27 | — | — | EP | disclosed |
| EP-2090323-B1 | Hyperbranched polymer conjugates via non-enzymatic cleavable linker | ASCENDIS PHARMA GROWTH DISORDERS DIVISION AS (DK) | 2016-07-27 | — | — | EP | disclosed |
| WO-2002079172-A1 | METHOD FOR PREPARING MONOCYCLIC $I(N)-ACYL-AMINOLACTAM COMPOUNDS AND COMBINATORIAL LIBRARIES THEREOF | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-10-10 | — | — | WO | disclosed |
| US-5614519-A | (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists | KARL THOMAE GMBH (DE) | 1997-03-25 | — | — | US | disclosed |
| US-5602127-A | ADMINISTERING TO TREAT HYPERTENSION | KARL THOMAE GMBH (DE) | 1997-02-11 | — | — | US | disclosed |
| US-5594003-A | HYPOTENSIVE AGENTS | DR. KARL THOMAE GMBH (DE) | 1997-01-14 | — | — | US | disclosed |